Načítá se...

727. Potency of the β-Lactamase Inhibitor QPX7728 Is Minimally Affected by KPC Mutations that Reduce Potency of Ceftazidime–Avibactam

BACKGROUND: In the United States, carbapenem-resistant Enterobacteriaceae (CRE) are mainly represented by KPC-producing strains and ceftazidime–avibactam (C/A) is increasingly used to treat infections caused by KPC-producers. C/A resistant (C/A-R) mutants with mutations in bla(KPC) can be isolated i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Lomovskaya, Olga, Nelson, Kirk J, Rubio-Aparicio, Debora
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6810935/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.795
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!